Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin

Cancer

Volumn 83, Issue 1, 1998, Pages 148-157

  Heller, Richard ^a,b,c   Jaroszeski, Mark J ^a   Reintgen, Douglas S ^a,b   Puleo, Chris A ^a,b   DeConti, Ronald C ^b   Gilbert, Richard A ^c   Glass, Lewis F ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c University of South Florida   (United States)

Author keywords

Basal cell carcinoma; Electrochemotherapy and bleomycin; Electroporation; Kaposi's sarcoma; Melanoma; Squamous cell carcinoma

Indexed keywords

BLEOMYCIN;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ELECTROCHEMOTHERAPY; FEMALE; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; KAPOSI SARCOMA; MALE; MELANOMA; MUSCLE CONTRACTION; PRIORITY JOURNAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS TISSUE TUMOR;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0032127362     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W     Document Type: Article

References (43)

1. Powell KT, Morgenthaler AW, Weaver JC. Tissue electroporation: observation of reversible electrical breakdown in viable frog skin. Biophys J 1989;56:1163-71.
2. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. PNAS 1993;90:10504-8.
3. Grasso RJ, Heller R, Cooley JC, Haller EM. Electrofusion of individual animal cells directly to intact corneal epithelial tissue. Biochim Biophys Acta 1989;980:9-14.
4. Heller R, Grasso RJ. Transfer of human membrane surface components by incorporating individual human cells into intact animal tissue by cell-tissue electrofusion in vivo. Biochim Biophys Acta 1990;1024:185-8.
5. Heller R, Gilbert R. Biological applications of cell-tissue electrofusion, In: Chang DC, Chassy BM, Saunders JA, Sowers AE, editors. Guide to electroporation and electrofusion. San Diego: Academic Press, Inc., 1992:393-410.
6. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988;175:15-25.
7. Orlowski S, Belehradek J Jr., Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Biochem Pharmacol 1988;37:4727-33.
8. Chang DC, Chassy BM, Saunders JA, Sowers AE, editors. Guide to electroporation and electrofusion. San Diego: Academic Press, 1992.
9. Mir LM, Orlowski S, Belehradek J Jr., Paoletti C. Electrochemotherapy: potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68-72.
10. Belehradek J Jr., Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumors in mice. Eur J Cancer 1991;27:73-6.
11. Balch CM, Houghton AN, Peters LJ. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. Table 46-7. Philadelphia: J.B. Lippincott, 1993:1637.
12. Retsas S. Strategies for improving survival in malignant melanoma; focus on vindesine. J Drug Devel Clin Pract 1995;7: 159-71.
13. Pron G, Belehradek J Jr., Mir LM. Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun 1993;194:333-7.
14. Muraoka Y, Takita T. Bleomycins. Cancer Chemother Biol Response Modif 1990;11:58-66.
15. Mir LM, Tounekti O, Orlowski S. Bleomycin: review of an old drug. Gen Pharmacol 1996;27:745-8.
16. Povirk LF, Hogan M, Dattagupta N. Binding of bleomycin to DNA: intercalation of the bithiazole rings. Biochemistry 1979;18:96-101.
17. Okino M, Marumoto M, Kanesada H, Kuga K, Mohri H. Electrical impulse chemotherapy for rat solid tumors. Proc Jpn Cancer Congress 1987;46:420.
18. Okino M, Esato K. The effects of a single high voltage electrical stimulation with anticancer drug on in vivo growing malignant tumors. Jpn J Surg 1990;20:197-204.
19. Okino M, Tomie H, Kanesada H, Marumoto M, Morita N, Esato K, et al. Induction of tumor specific selective toxicity in electrical impulse chemotherapy: analysis of dose response curve. Oncologia 1991;24:71-9.
20. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992;83:1095-101.
21. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma. J Jpn Soc Cancer Ther 1990;25: 2640-8.
22. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PCh, Mir LM. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Comm 1993;194:938-43.
23. Heller R, Jaroszeski M, Leo-Messina J, Perrott R, Van Voorhis N, Reintgen D, et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem Bioenerget 1995;36:83-7.
24. Sersa G, Cemazar M, Miklavcic D, Mir LM. Electrochemotherapy: variable antitumor effect on different tumor models. Bioelectrochem Bioenerget 1994;35:23-7.
25. Yamaguchi O, Irisawa C, Baba K, Ogihara M, Yokota T, Shiraiwa Y. Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tohoku J Exp Med 1994;172:291-3.
26. Dev SB, Hofmann GA. Electrochemotherapy: a novel method of cancer treatment. Cancer Treat Rev 1994;20:105-15.
27. Jaroszeski MJ, Gilbert R, Heller R. Successful treatment of hepatomas with electrochemotherapy in a rat model. Biochim Biophys Acta 1997;1334:15-8.
28. Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin J Jr., Schwab G, et al. Electrochemotherapy, a novel antitumor treatment: first clinical trial. CR Acad Sci Paris 1991;313: 613-8.
29. Belehradek M, Domenge C, Luboinnski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumor treatment: first clinical phase I-II trial. Cancer 1993;72: 3694-700.
30. Heller R. Treatment of cutaneous nodules using electrochemotherapy. J Florida Med Assoc 1995;82:147-50.
31. Rudolf Z, Stabuc B, Cemazar M, Miklavcic D, Vodovnik L, Sersa G. Electrochemotherapy with bleomycin: the first clinical experience in malignant melanoma patients. Radiol Oncol 1995;29:229-35.
32. Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek J Jr., et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996;77:956-63.
33. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996;77:964-71.
34. Reintgen DS, Jaroszeski MJ, Heller R. Electrochemotherapy: a novel approach to cancer. J Skin Cancer Foundation 1996; XIV: 17-9,83.
35. Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1997;7: 10-8.
36. Jaroszeski M, Gilbert R, Perrott R, Heller R. Effectiveness of treating B16 melanoma with multiple treatment electrochemotherapy. Melanoma Res 1996;6:427-33.
37. Hofmann GA, Dev SB, Nanda GS. Electrochemotherapy: transition from laboratory to the clinic. IEEE Eng Med Biol 1996;15:124-32.
38. Gilbert R, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997;1334: 9-14.
39. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-dichlorodiammineplatinum (II) in mice. Cancer Res 1995;55:3450-5.
40. Poddevin B, Orlowski S, Belehradek J Jr., Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991;42(Suppl):67-75.
41. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992;3:331-4.
42. Mir LM, Roth C, Orlowski S, Belehradek J Jr., Fradelizi F, Paoletti C, et al. Potentiation of the antitumoral effect of electrochemotherapy by an immunotherapy with allogeneic cells producing interleukin-2. CR Acad Sci Paris 1992;314: 539-44.
43. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi F, Belehradek J Jr., et al. Systemic antitumor effects of electrochemotherapy combined with histocompatible cells secreting interleukin-2. J Immunol 1995;17:30-8.